Explore 10 TAVR Valve Types for Better Heart Health

Explore 10 TAVR Valve Types for Better Heart Health

Introduction

Transcatheter Aortic Valve Replacement (TAVR) has truly transformed the way we approach aortic stenosis treatment, offering a variety of valve types tailored to meet the unique needs of each patient. As we witness ongoing advancements in TAVR technology, it’s essential to grasp the distinct features and benefits of these valves. How can you, as a patient, navigate these options to ensure the best outcomes for your heart health?

This article explores ten innovative TAVR valve types, shedding light on their unique advantages and the vital role they play in enhancing cardiovascular care. Together, we’ll delve into these options, ensuring you feel informed and supported every step of the way.

Amavita Heart and Vascular Health: Leading TAVR Innovations

At Amavita Heart and Vascular Health, we understand that facing heart issues can be daunting. That’s why we’re proud to lead in innovations in , providing you with access to the latest advancements in . Founded by Harvard-educated Dr. Pedro Martinez-Clark, our practice blends cutting-edge methods with compassionate care, ensuring the best possible outcomes for those dealing with .

Imagine being able to undergo , like or heart repair, in a comfortable outpatient setting and returning home the same day. We believe that cardiovascular care doesn’t always mean a hospital stay, and our modern centers reflect that commitment to your comfort and well-being.

Recent studies show that by 2021, the application levels of different for transcatheter aortic valve replacement were nearly on par with . This is especially encouraging for individuals under 65, as it highlights the growing acceptance of across all age groups. For our elderly patients, the utilization of has become a favored option, with rates exceeding 98% for those over 80 years old.

At Amavita, we’re dedicated to enhancing your quality of life. Our involvement in offers access to innovative therapies, including the promising , which is designed to mimic a healthy aortic structure. While it’s important to note that the hasn’t yet received FDA approval, its potential to improve performance and longevity is exciting.

By focusing on in our outpatient centers, we prioritize your comfort and aim to reduce recovery times. This makes Amavita a preferred choice for elderly individuals seeking expert cardiovascular care. If you have any questions or concerns, please don’t hesitate to reach out. We’re here to support you every step of the way.

The central node represents TAVR innovations, with branches showing different aspects like valve types and patient demographics. Each color-coded branch helps you navigate through the information easily.

SAPIEN 3: A Revolutionary TAVR Valve for Enhanced Outcomes

The represents a significant step forward in (TAVR) technology. Its balloon-expandable design allows for precise placement and optimal hemodynamic performance, which is crucial for patients like you. This innovative approach greatly reduces the risk of paravalvular leak, a common complication, ultimately leading to better outcomes for individuals.

Recent clinical studies have shown that patients receiving the experience and a better quality of life after their procedures. This is especially important for elderly patients, who often face higher risks of complications. For instance, the revealed a 10% all-cause mortality rate, underscoring the device's reliability and durability.

Moreover, expert evaluations confirm that the advanced design and improved procedural methods contribute to a low incidence of adverse events. This solidifies the as a for those suffering from .

In addition to this, by utilizing - such as those involving - healthcare facilities can further enhance the effectiveness of TAVR procedures. This not only helps in reducing but also improves overall patient care.

If you or a loved one are considering TAVR, know that there are compassionate options available to support your journey towards .

This mindmap illustrates the key aspects of the SAPIEN 3 TAVR valve. Start at the center with the valve itself, then explore the branches to see its design features, clinical outcomes, patient benefits, and management strategies that enhance its effectiveness.

EVOLUT R: Advanced Design for Optimal Heart Function

At Amavita Heart and Vascular Health®, we understand that navigating health concerns can be daunting, especially for those with complex anatomies. That’s why we’re proud to offer the EVOLUT R device, which features a self-expanding design that makes deployment and repositioning during procedures much easier. This adaptability not only ensures a better fit but also significantly reduces the risk of complications, giving you peace of mind.

We utilize to enhance the application of the EVOLUT R device in our . , including the , have shown promising results. For instance, the device demonstrated at five years:

  1. 15.5% for
  2. 16.4% for surgery

Additionally, cardiovascular mortality rates were:

  1. 7.2% for
  2. 9.3% for surgery

These findings highlight the EVOLUT R device as a leading option among in the market, offering enhanced and a supportive alternative for patients undergoing aortic replacement.

As Dr. Michael J. Reardon notes, the device's further reinforce its role in contemporary . At Amavita, we are committed to providing innovative, patient-centered approaches that prioritize your well-being. If you have any questions or concerns, please don’t hesitate to reach out. We’re here to support you every step of the way.

This chart shows the outcomes for two treatment options: the larger the slice, the higher the percentage of mortality or complications. It helps you see how the EVOLUT R device compares to traditional surgery in terms of patient safety.

PORTICO: Flexible TAVR Valve for Tailored Treatments

The PORTICO device is designed with your needs in mind, featuring a that allows for precise placement and resheathing when necessary. This flexibility is crucial for achieving the , especially for patients facing various anatomical challenges. Clinical data shows that the PORTICO device performs exceptionally well, boasting a and low complication rates, including a significant of just 11.2%.

In addition to this, the moderate paravalvular leak rate has decreased from 3.9% at 30 days to 2.6% at one year, highlighting its reliability. Many professionals emphasize how this device can navigate complex cardiac structures, making it a valuable option for personalized using different TAVR valve types.

With a focus on , the PORTICO device truly stands out as a leading choice for those who need tailored interventions. If you or a loved one are considering options for heart care, know that support is available, and we are here to help you every step of the way.

The green slice shows the high success rate of the PORTICO device, while the red slices indicate the rates of complications. The larger the slice, the better the performance in that area.

ACURATE NEO: Innovative Delivery for Effective Valve Replacement

Are you or a loved one facing ? It’s a concern that many share, and we understand how daunting it can feel. The is here to help, featuring an innovative delivery system that enhances the precision of its placement during . This thoughtful design aims to minimize complications and boost the overall success of the procedure, giving you peace of mind.

Clinical studies have shown that the delivers outstanding . This establishes it as a reliable option among the for individuals undergoing TAVR. At Amavita Heart and Vascular Health®, we prioritize your well-being by focusing on advanced diagnostic imaging and tailored to your unique needs.

Our outpatient approach allows most individuals to return home the same day, quickly experiencing relief from symptoms. We believe in providing thorough assessments and to enhance heart health outcomes for those we serve. Remember, you’re not alone in this journey; we’re here to support you every step of the way.

The central node represents the ACURATE NEO device, while the branches show its key features and benefits. Each color-coded branch helps you easily identify different aspects of the device and how they contribute to better patient outcomes.

LOTUS: Enhanced Sealing for Improved Patient Outcomes

Are you concerned about the risks associated with heart procedures? The stands out with its , which significantly lowers the chances of paravalvular leaks. This feature is crucial for ensuring optimal hemodynamic performance and improving your overall health outcomes.

Clinical trials reveal that individuals who receive the experience after their procedure. This makes it a reassuring choice for those undergoing , especially considering the available.

In addition to this, Amavita's CardioElite™ program enhances your experience by offering . This program integrates advanced diagnostic tools and ensures seamless coordination of care. By doing so, it not only highlights the benefits of the but also plays a vital role in reducing hospital readmissions and improving health results.

We understand that navigating health decisions can be daunting. If you have questions or need support, please don’t hesitate to reach out. Your are our top priorities.

The central node represents the LOTUS device, while the branches show its various benefits and how they contribute to better health outcomes. Each color-coded branch helps you easily identify different aspects of the device's advantages.

JENAVALVE: A Unique Approach to TAVR Solutions

Are you or a loved one facing the challenges of ? that ensures stable positioning within the native valve, which is crucial for your peace of mind. This thoughtful design not only promotes effective sealing but also significantly reduces the risk of complications, allowing you to focus on what truly matters - your health and well-being.

Clinical studies reveal that the JENAVALVE achieves an impressive , with a one-year mortality rate of just 8.1%. These numbers are not just statistics; they represent real lives improved and futures brightened. Many individuals have reported significant enhancements in their after the procedure, making the JENAVALVE a compelling choice among the various in the evolving landscape of TAVR solutions.

In addition to these remarkable outcomes, we understand that making health decisions can be daunting. It’s natural to have questions and concerns. We’re here to support you every step of the way. If you’re considering options for your , don’t hesitate to reach out for more information. Your journey towards a is important, and we’re committed to helping you navigate it with care and compassion.

The green slice shows the high success rate of the JENAVALVE, meaning most patients experience positive results. The red slice represents the mortality rate, indicating the percentage of patients who may face risks. Together, these slices help you understand the balance of outcomes associated with this treatment.

ALLEGRA: Innovative Design for Enhanced Heart Health

Are you or a loved one facing the challenges of severe ? The might be the solution you’ve been looking for. Meticulously engineered, it offers exceptional hemodynamic performance and is designed for precise positioning during implantation. have shown that this device can , providing hope and relief.

One of the most reassuring aspects of the is its impressive . Patients have reported no major complications, such as strokes or life-threatening bleeding, up to 12 months after the procedure. Furthermore, the mean pressure gradient across the aortic structure decreased significantly, from 30.75 mm Hg at baseline to just 14.75 mm Hg at 30 days. This indicates that the device is functioning effectively, helping to .

With these encouraging results, the ALLEGRA apparatus stands out as a top choice in the rapidly advancing field of . It offers not just a medical solution, but a renewed sense of hope for improved . If you have concerns about your , don’t hesitate to reach out for support. You deserve the best care possible.

This mindmap illustrates the key benefits of the ALLEGRA device. Each branch represents a different aspect of its performance, helping you understand how it contributes to better heart health.

Understanding TAVR Valve Types: Key to Informed Choices

Transcatheter Aortic Replacement (TAVR) provides various that are tailored to meet individual needs and anatomical considerations. The two primary include , like the SAPIEN 3, and self-expanding structures, such as the EVOLUT R. Understanding these differences is essential for both patients and healthcare providers, as it can significantly and outcomes.

are deployed using a balloon catheter, ensuring a precise fit in the aortic annulus. On the other hand, feature a unique design that allows them to expand naturally upon deployment, accommodating a broader range of anatomical variations. Clinical insights suggest that may be more effective in certain situations, particularly for individuals with smaller annuli, where they have shown lower rates of complications like pacemaker implantation and stroke.

If you’re experiencing signs of , such as shortness of breath or fatigue, it’s understandable to feel concerned about your quality of life. That’s why expert opinions emphasize the importance of a when selecting the right device. Factors like your anatomy, existing health conditions, and overall well-being play a crucial role in determining the best option for you. Recent studies indicate that while both device types can achieve similar mortality rates at 30 days, the occurrence of major bleeding and other complications can differ, highlighting the need for .

In summary, understanding the differences between balloon-expandable and self-expanding transcatheter aortic devices, which are among the various , is vital for making informed decisions. This knowledge can lead to better procedural success and outcomes for you. At Amavita, we prioritize to ensure that you receive a personalized approach to your heart health, including the possibility of same-day discharge, which can enhance your recovery and overall satisfaction. Remember, you’re not alone in this journey; we’re here to support you every step of the way.

The central node represents the overall topic of [[TAVR valve types](https://amavita.health/blog/find-heart-testing-near-me-a-step-by-step-guide-for-seniors)](https://amavita.health/blog/find-heart-testing-near-me-a-step-by-step-guide-for-seniors). Each branch shows a different type of valve, with further details about their characteristics and considerations. This helps you see how each type differs and what factors to consider when making a choice.

The Impact of TAVR Valves on Heart Health: A Summary

have truly transformed how we treat aortic stenosis, providing a that can significantly enhance heart health and . At Amavita Heart and Vascular Health®, we understand that navigating health concerns can be daunting, especially for those at higher risk. That’s why we use , like echocardiography and cardiac MRI, along with thorough assessments, to ensure you receive focused tailored just for you.

Recent advancements in , including improved sealing mechanisms, flexible designs, and innovative delivery systems, have led to better outcomes, fewer complications, and quicker recovery times. Did you know that clinical studies show the in-hospital mortality rate for is around 1%, with stroke rates close to 2%? This highlights the safety of this procedure, which is especially important for older individuals who may face greater risks with traditional surgeries.

As this technology continues to evolve, it’s expected to further enhance treatment options for cardiovascular issues, including different , making it accessible to even more people. We want you to feel reassured that the for not only improves safety but also broadens its availability, ensuring that more individuals can benefit from this life-saving therapy.

Additionally, our CardioElite™ program is designed to enhance proactive patient management. It directly supports TAVR procedures by reducing readmissions and ensuring comprehensive that meets your unique needs. If you have any questions or concerns, please don’t hesitate to reach out. We’re here to support you every step of the way.

Start at the center with the main topic, then follow the branches to explore advancements, safety data, and how patient management supports TAVR procedures. Each branch represents a key area of focus, helping you see the full picture of how TAVR valves improve heart health.

Conclusion

In conclusion, TAVR valve types represent a remarkable advancement in treating aortic stenosis, providing patients with a minimally invasive option that can lead to significant improvements in heart health and overall quality of life. At Amavita Heart and Vascular Health, the innovations in TAVR technology highlight the importance of personalized care and a commitment to using cutting-edge methods to ensure the best possible outcomes for patients.

As we explore the various TAVR valve types, it’s clear that each design offers unique benefits. Devices like the SAPIEN 3 and EVOLUT R feature advanced capabilities that enhance procedural success and minimize complications. Meanwhile, options such as the PORTICO and LOTUS cater to patients with complex anatomical challenges, ensuring that everyone receives the care they need. Each valve type has undergone thorough evaluation through clinical trials, proving their effectiveness and reliability in improving patient care.

As TAVR technology continues to evolve, it’s essential for individuals facing heart health challenges to stay informed and engaged with their treatment options. The ongoing advancements in TAVR valve types not only enhance safety and accessibility but also pave the way for better health outcomes. Have you considered discussing your options with a healthcare professional? Participating in comprehensive evaluations can empower you to make informed decisions about your heart health, ensuring you receive the best possible care on your journey toward recovery. Remember, you’re not alone in this; support is available every step of the way.

Frequently Asked Questions

What is Amavita Heart and Vascular Health known for?

Amavita Heart and Vascular Health is known for leading innovations in TAVR (transcatheter aortic valve replacement) valve types, providing access to the latest advancements in heart technology, and offering compassionate care for patients with aortic stenosis.

Who founded Amavita Heart and Vascular Health?

Amavita Heart and Vascular Health was founded by Dr. Pedro Martinez-Clark, who is Harvard-educated.

What types of procedures does Amavita offer?

Amavita offers advanced heart and vascular procedures such as cardiac catheterization and heart repair, typically in a comfortable outpatient setting where patients can return home the same day.

How has the acceptance of TAVR valve types changed over time?

By 2021, the application levels of different TAVR valve types were nearly on par with surgical aortic valve replacement, particularly encouraging for individuals under 65. For patients over 80, TAVR valve types have become a favored option, with utilization rates exceeding 98%.

What innovative therapies does Amavita participate in?

Amavita is involved in clinical trials offering access to innovative therapies, including the DurAVR THV system, which aims to mimic a healthy aortic structure, though it has not yet received FDA approval.

What is the SAPIEN 3 device and its significance?

The SAPIEN 3 device is a revolutionary TAVR valve with a balloon-expandable design that allows for precise placement and optimal hemodynamic performance, reducing the risk of complications and improving patient outcomes.

What are the outcomes associated with the SAPIEN 3 device?

Patients receiving the SAPIEN 3 device have shown improved survival rates and better quality of life, with a five-year follow-up from the PARTNER 3 trial indicating a 10% all-cause mortality rate.

How does the EVOLUT R device enhance TAVR procedures?

The EVOLUT R device features a self-expanding design that facilitates easier deployment and repositioning, significantly reducing the risk of complications and ensuring a better fit for patients.

What clinical trial results support the EVOLUT R device?

The Evolut Low Risk Trial showed that the EVOLUT R device had lower rates of all-cause mortality and disabling stroke compared to surgery, with 15.5% for transcatheter aortic intervention versus 16.4% for surgery.

How does Amavita prioritize patient care?

Amavita focuses on innovative, patient-centered approaches that prioritize patient comfort and well-being, utilizing advanced imaging and comprehensive evaluations to enhance cardiovascular care.

List of Sources

  1. Amavita Heart and Vascular Health: Leading TAVR Innovations
  • Medtronic invests $90M in medtech company behind one-of-a-kind TAVR tech (https://cardiovascularbusiness.com/topics/clinical/structural-heart-disease/tavr/medtronic-invests-90m-medtech-company-behind-one-kind-tavr-tech)
  • National Trends in TAVR and SAVR for Severe Aortic Stenosis - American College of Cardiology (https://acc.org/Latest-in-Cardiology/Journal-Scans/2022/09/16/02/12/National-Trends-in-TAVR-TCT-2022)
  • Contemporary Incidence and Procedural Volume of Transcatheter Aortic Valve Reintervention (https://jamanetwork.com/journals/jamacardiology/fullarticle/2839154)
  1. SAPIEN 3: A Revolutionary TAVR Valve for Enhanced Outcomes
  • Newest TAVR valve from Edwards Lifesciences improves survival, real-world data confirm (https://cardiovascularbusiness.com/topics/clinical/structural-heart-disease/tavr/newest-tavr-valve-edwards-lifesciences-improves-survival-real-world-data-confirm)
  • Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients: (https://jacc.org/doi/10.1016/j.jacc.2023.04.049)
  • Five-year Data from Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve (https://dicardiology.com/content/five-year-data-partner-3-trial-demonstrate-excellent-survival-patients-receiving-edwards)
  • One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis | Circulation (https://ahajournals.org/doi/10.1161/circulationaha.116.022797)
  • In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry (https://eurointervention.pcronline.com/article/sapien-3-ultra-balloon-expandable-transcatheter-aortic-valve-in-hospital-and-30-day-results-from-the-multicentre-s3u-registry)
  1. EVOLUT R: Advanced Design for Optimal Heart Function
  • Medtronic's Evolut TAVR System Shows Promising 5-Year Outcomes in Low-Risk Patients: ACC 2025 Late-Breaking Data (https://mddionline.com/cardiovascular/medtronic-breaks-out-strong-tavr-data-at-acc)
  • Medtronic’s Evolut TAVR System Evaluated in Low-Risk Patients at 5 Years - Cardiac Interventions Today (https://citoday.com/news/medtronics-evolut-tavr-system-evaluated-in-low-risk-patients-at-5-years)
  • Medtronic reports late-breaking data from TAVR system trial for aortic stenosis (https://medicaldevice-network.com/news/medtronic-tavr-system-trial)
  • Medtronic’s Evolut TAVR Demonstrates Durable Outcomes at Five Years in Low-Risk Patients with Severe Aortic Stenosis (https://biopharmaboardroom.com/news/6/3121/medtronics-evolut-tavr-demonstrates-durable-outcomes-at-five-years-in-low-risk-patients-with-severe-aortic-stenosis.html)
  1. PORTICO: Flexible TAVR Valve for Tailored Treatments
  • Real-Life Performance and Clinical Outcomes of Portico Transcatheter Aortic Valve with FlexNav Delivery System: One-Year Data from a Single-Center Experience - PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC10455755)
  • Abbott Receives CE Mark Approval of FlexNav Delivery System for Portico Valve - Cardiac Interventions Today (https://citoday.com/news/abbott-receives-ce-mark-approval-of-flexnav-delivery-system-for-portico-valve)
  • Abbott Receives FDA Approval for Minimally Invasive Portico™ with FlexNav™ TAVR System to Treat Patients with Aortic Valve Disease (https://abbott.mediaroom.com/2021-09-20-Abbott-Receives-FDA-Approval-for-Minimally-Invasive-Portico-TM-with-FlexNav-TM-TAVR-System-to-Treat-Patients-with-Aortic-Valve-Disease)
  • One-Year Results From PORTICO I Presented for Abbott's Portico TAVR Device - Cardiac Interventions Today (https://citoday.com/news/one-year-results-from-portico-i-presented-for-abbotts-portico-tavr-device)
  • Abbott’s Portico With FlexNav TAVR System Receives FDA Approval - Cardiac Interventions Today (https://citoday.com/news/abbotts-portico-with-flexnav-tavr-system-receives-fda-approval)
  1. ACURATE NEO: Innovative Delivery for Effective Valve Replacement
  • Boston Scientific Discontinues Acurate Neo2 and Acurate Prime TAVR Systems - Cardiac Interventions Today (https://citoday.com/news/boston-scientific-discontinues-acurate-neo2-and-acurate-prime-tavr-systems)
  • Boston Scientific Strikes Out with Yet Another TAVR Platform (https://mddionline.com/cardiovascular/boston-scientific-strikes-out-with-yet-another-tavr-platform)
  • Boston Scientific discontinues Acurate TAVR sales, cites regulatory burden (https://massdevice.com/boston-scientific-discontinues-acurate-tavr-sales-cites-regulatory-burden)
  • Boston Scientific’s TAVR hopes dashed again, as it pulls Acurate heart valves from global market (https://fiercebiotech.com/medtech/boston-scientifics-tavr-hopes-dashed-again-it-pulls-acurate-heart-valves-global-market)
  1. LOTUS: Enhanced Sealing for Improved Patient Outcomes
  • Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System (https://news.bostonscientific.com/2019-04-23-Boston-Scientific-Receives-FDA-Approval-for-LOTUS-Edge-TM-Aortic-Valve-System)
  • Boston Scientific Throws in the Towel on Lotus TAVR Platform (https://mddionline.com/cardiovascular/boston-scientific-throws-in-the-towel-on-lotus-tavr-platform)
  • Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial - PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC9614584)
  • Transcatheter aortic valve replacement with Lotus and Sapien 3 prosthetic valves: a systematic review and meta-analysis - PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC7139024)
  • Boston Scientific Pulls Lotus Edge TAVR Valve Off The Market (https://dicardiology.com/article/boston-scientific-pulls-lotus-edge-tavr-valve-market)
  1. JENAVALVE: A Unique Approach to TAVR Solutions
  • Edwards Comments on JenaValve Acquisition (https://edwards.com/newsroom/news/2026-01-09-edwards-comments-on-jenavalve-acquisition)
  • Edwards Acquisition of JenaValve Called Off - Cardiac Interventions Today (https://citoday.com/news/edwards-calls-off-acquisition-of-jenavalve)
  • New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves (https://jenavalve.com/new-late-breaking-results-from-the-align-ar-trial)
  • JenaValve reports positive Trilogy heart valve data for AR (https://massdevice.com/jenavalve-positive-heart-valve-data-ar)
  • New transcatheter valve safe, effective for treating aortic regurgitation (https://medicalxpress.com/news/2025-03-transcatheter-valve-safe-effective-aortic.html)
  1. ALLEGRA: Innovative Design for Enhanced Heart Health
  • Allegra TAVR System Feasible for Treating Degenerated Surgical Valves (https://tctmd.com/news/allegra-tavr-system-feasible-treating-degenerated-surgical-valves)
  • One-year clinical outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: the VIVALL study - PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC9724868)
  • Thirty-day outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: the VIVALL multicentre, single-arm, pilot study (https://eurointervention.pcronline.com/article/thirty-day-outcomes-of-a-novel-transcatheter-heart-valve-to-treat-degenerated-surgical-valves-the-vivall-multi-center-single-arm-pilot-study)
  • Current TAVR Devices - Cardiac Interventions Today (https://citoday.com/articles/2017-mar-apr/current-tavr-devices)
  1. Understanding TAVR Valve Types: Key to Informed Choices
  • Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration - PubMed (https://pubmed.ncbi.nlm.nih.gov/30590565)
  • Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus - American College of Cardiology (https://acc.org/About-ACC/Press-Releases/2024/04/07/13/57/self-expanding-valve-outperforms-balloon-expandable-valve-for-tavr-in-patients-with-small-valve-annulus)
  • Choice between self-expanding, balloon-expandable TAVR valve multifaceted decision (https://healio.com/news/cardiology/20230426/choice-between-selfexpanding-balloon-expandable-tavr-valve-multifaceted-decision)
  • Balloon, Self-Expanding TAVI Devices Provide Similar Results in Bicuspid Valves (https://tctmd.com/news/balloon-self-expanding-tavi-devices-provide-similar-results-bicuspid-valves)
  • Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement | Circulation (https://ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.043785)
  1. The Impact of TAVR Valves on Heart Health: A Summary
  • Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe (https://medtechdive.com/news/edwards-medtronic-abbot-tavr-guidelines-europe/759089)
  • Patient files lawsuit over recall | Heart teams playing a major role | Abbott TAVR valve impresses | Preventing heart failure | Cardiovascular Business (https://cardiovascularbusiness.com/newsletter/2026-01-19/patient-files-lawsuit-over-recall-heart-teams-playing-major-role-abbott-tavr-valve-impresses)
  • Developments in Transcatheter Aortic Valve Replacement (https://thecardiologyadvisor.com/cch/transcatheter-aortic-valve-replacement-aortic-stenosis-quality-of-life)
Author: amavita Heart and Vascular Health® Content Team